Ulka N. Vaishampayan, MBBS, FAB, discusses the updated data from CheckMate 214 of nivolumab and ipilimumab versus sunitinib in patients with previously untreated advanced or metastatic renal cell carcinoma.
Ulka Nitin Vaishampayan, MBBS, FAB
Articles by Ulka Nitin Vaishampayan, MBBS, FAB